DIGIPHARM - Bringing value-based healthcare to life using blockchain technology
Hello all!
Digipharm bringing value-based healthcare to life and in the manner of utilise innovative blockchain technology, Digipharm will overcome barriers to patient access and innovative pricing, reduce costs for all stakeholders, and bypass infrastructural limitations to drive value improvement, incentivise innovation and expedite the transformation to personalised healthcare.
Our Vision
To be the pioneer of sustainable and value-based healthcare delivery, innovative evidence generation and patient empowerment across the healthcare industry.
The Future of Healthcare
- Value Based Care
Healthcare systems around the world are currently threatened by challenges unique to our time; unsustainable expenditure, ageing populations and the increasing prevalence of chronic diseases. The concept of value based healthcare proposes that payment for healthcare should be tied to the quality of care and the benefits it provides; switching from a ‘fee for service’ to a ‘fee for performance’ reimbursement model.
- Innovative Pricing
Innovative pricing solutions such as value-based pricing offer an increasingly dynamic solution to address the uncertainty around the cost of treatment relative to patient outcomes. Such mechanisms reward manufacturers and providers for improving patient outcomes, incentivise innovation and encourage the transition to patient centric healthcare.
- Pioneering Evidence Generation
Innovative evidence generation solutions are necessary to satisfy the requirement of relevant, timely and quality data to inform the provision of optimised value based healthcare. Circumventing the use of static or retrospective data will open the horizon to superior forecasting, confidence in decision making and global oversight with regards to current developments in an increasingly dynamic industry such as healthcare.
Our Flagship Solutions
- Reimburse
Reimburse will eliminate the infrastructural barriers and automate the implementation of value based pricing agreements, no matter how complex, on a fully independent global platform; encouraging personalised reimbursement of health technology on a ‘fee for performance’ basis for the mutual benefit of patients, payers and manufacturers.
- Accelerates access to high cost therapy
- Incentivises innovation
- Drastically reduces administrative costs
- Insights
Insights is the first ever ‘live’ real world evidence repository and allows the utilisation of real world evidence (RWE) as soon as it becomes available. The availability of ‘live’ RWE will provide stakeholders with real time intelligence with which they can inform decision making and product development across the medicinal lifecycle.
- Incentives for patients to contribute data
- Significant cost savings compared to conventional RWE sources
- Single platform for global evidence
Digipharm are strong believers in empowering patients with the custodianship and ownership of their personal data. Patients will be incentivised to share and contribute their health related data to inform decision making and health related research.
Up here the explanation from me and for more information please visit the Website here: https://www.digipharm.ch/ or Whitepaper here: https://digipharm.ch/docs/DigipharmWP.pdf and also the Links found below:
FACEBOOK:https://www.facebook.com/digipharmteam/
TELEGRAM:https://t.me/joinchat/ExOHxk-TuOplQDbBWXaLaQ
MEDIUM:https://medium.com/@digipharm
REDDIT:https://www.reddit.com/r/Digipharm
TWITTER:https://twitter.com/DigipharmTeam
LINKEDIN:https://www.linkedin.com/company/11360677/
YOUTUBE:https://www.youtube.com/channel/UCtZuSfZBVdKErQtbO9Ql4Pg
Author: Sadum
Link to profile:https://bitcointalk.org/index.php?action=profile;u=1393441